Event Summary
On May 6, following introductory remarks by Chairman of the House Permanent Select Committee on Intelligence Mike Turner (R-OH), Rep. Brad Wenstrup (R-OH) moderated a panel with AEI’s Dan Blumenthal, Anna Puglisi of Puglisi Ventures, Anthony Ruggiero of the Foundation for Defense of Democracies, Palantir’s Ken Staley, and Dov S. Zakheim of the National Security Commission on Emerging Biotechnology.
Panelists discussed the state of US biosecurity, China’s efforts to gain leverage in biosecurity research processes, and what the US can learn from its experience combating COVID-19. Panelists also reviewed the United States’ lack of preparedness for combating bioweapons and naturally occurring pathogens, underscoring the need to research new technologies, protect existing supply chains, and determine how best to work with existing international organizations. Throughout the event, panelists highlighted the threats China poses regarding biotechnology and bioweapons development, as well as China’s previous efforts to stymie cooperation within the World Health Organization and other international organizations. Lastly, panelists provided recommendations to develop government strategy on biotechnology production, forge mechanisms for cooperation with our allies, and invest in technology to detect future disease outbreaks.
—Alexis Turek
Event Description
The artificial intelligence and biotechnology sectors have developed and been deployed into people’s daily lives faster than any other technologies have. While these technologies are in the early stages of being incorporated into education, health care, and research industries, adversaries are already developing new, threatening capabilities using AI and biotechnology. Rivals such as China are competing intensely with the US in generative AI, drug development, and other biotechnology elements.
Rep. Brad Wenstrup (R-OH) will lead a panel of experts to discuss how policymakers can combat the threats posed by these evolving technologies and the ways Congress could secure the AI and biotechnology fields.